Stocks to Watch: LinkedIn Corp (NYSE:LNKD), Spectrum Pharmaceuticals, Teradyne, Inc.(NYSE:TER),

Lakeway, NY -- (SBWIRE) -- 03/19/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

LinkedIn Corp (NYSE:LNKD) shares decreased 1.81% and closed at $174.28. The company, on Mar. 14, announced that its membership base in Australia has surpassed four million, a 300% growth since 2010. Globally, the site attracts more than two new members every second, and grew to more than 200 million members worldwide in December. With approximately 5 million professionals in Australia, LinkedIn is now home to over 80% of the country's professional population.

Get Latest News, Updates on LNKD Here

Spectrum Pharmaceuticals, Inc.(NASDAQ:SPPI) shares decreased 1.80% to $7.62. The company, on Mar. 14, announced that it has gained global development and commercialization rights to Ligand Pharmaceuticals' (NASDAQ: LGND) Captisol-enabled®, propylene glycol-free (PG-free) melphalan. Captisol-enabled melphalan is currently in a pivotal trial for use as a conditioning treatment prior to autologous stem cell transplant for patients with multiple myeloma.

Is SPPI a Strong Buying Opportunity After The Recent Gain? Find out Here

Additionally, the company on Mar. 12, said full-year sales would fall far short of analysts’ estimates. Annual 2013 revenue will be $160 million to $180 million. Analysts anticipated total revenue of $297 million. The company said sales of its top product, Fusilev, will be $80 million to $90 million.

Teradyne, Inc.(NYSE:TER) shares decreased 1.78% and closed at $16.53. The company will present, to a growing Chinese market, focused low-cost ATE solutions in booth #3121 at SEMICON China held in Shanghai on March 19-21. Teradyne will display and perform product demonstrations on the ETS-88, the J750Ex and the Magnum test cell.

Is TER a Strong Buying Opportunity After The Recent Slump? Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.